Overview
Status
Active
Registry date
2011-08-22
Share capital
115,826,550.00 PLN
Average employment (people)
357 (2025)
Registered address
Postępu 21B, 02-676 Warszawa, Poland
Electronic delivery address
AE:PL-56136-45846-VSUSA-15
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $2,118,958 | |
| Profit allocation | No decision | |
| Capital expenditure | $3,046,459 | |
| Planned capital expenditure (next year) | $301,356 | |
| Foreign sales | 29.12% of revenue ($65,827,938) | |
| Revenue structure | Sprzedaż towarów |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 44 days for 2025). All were audited by a statutory auditor.
- 202528/08/2026
- 202414/07/2025
- 202316/07/2024
- 202201/08/2023
- 202115/07/2022
- 202024/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles184 / 29,896
Top <1%
Results vs industry
Revenue
This companyUSD 226.12mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 9.07mMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 212.98mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 166.17mMedianUSD 609.81kAverageUSD 11.84m
Industry
Public procurement
725 tenders recorded as contractor: 134 national ($8,221,433) and 591 EU ($1,501,033,503).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 30, 2026 | Successive supplies of pharmaceutical products, oncology medicines covered by reimbursement under drug programmes and chemotherapy, medicines used in interferon-free therapy for hepatitis C, and vaccines to Wojewódzki Szpital Zespolony w Kaliszu | $3,713$3,713 | Wojewódzki Szpital Zespolony Im. Ludwika Perzyny w Kaliszu | |
| Oct 30, 2026 | Purchase and successive supply of oncology and other medicines. | $1.5M$1,461,922 | Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie | |
| Oct 29, 2026 | Supply of medicinal products and medical devices for Mazowiecki Szpital Bródnowski Sp. z o.o. | $78,123$78,123 | Mazowiecki Szpital Bródnowski sp. z o.o. |
Authorized Representatives
Aleksander Marek Kwieciński – Management Board Member
Beata Maria Przewuska – Management Board Member
Sławomir Dariusz Szymankiewicz – Management Board Member
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Abbvie Central Finance B.v. | 2,316,531 | $31,287,560.78 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-07-29.
73 1600 1127 1847 2463 5000 0001- 46 1600 1127 1847 2463 5000 0002
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.9MPLN 1,929,979 |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-11-02 | Share capital increase (5,000.00 PLN → 115,826,550.00 PLN) | |
| 2022-11-02 | PKD change (Removed: 9 codes; Added: 9 codes) | |
| 2015-04-09 | PKD change (Removed: 18 codes) | |
| 2012-05-30 | Address change (Pl. Piłsudskiego 1, 00-078, Warszawa → Postępu 21b, 02-676, Warszawa) | |
| 2012-04-23 | Name change (Borage → Abbvie) |
FAQ
Last updated: 2026-10-07